


The global animal feed peptide market is derived from Future Market Insights' broader "Animal Peptides Market" estimate of USD 900.2 million in 2025, growing at an 11.0% CAGR to reach USD 2,556.0 million by 2035. Because FMI's published scope explicitly spans pet food/treats and veterinary/injectable therapeutics alongside feed-relevant applications (poultry, ruminant, swine and aquaculture nutrition), this report applies an analyst-derived adjustment — based on FMI's own reported Animal Species value shares (Poultry 27.3%, Ruminants 21.6%, Swine 18.9%, summing to 67.8% unambiguously feed/livestock-relevant, plus an estimated ~14% for aquaculture) — to arrive at an estimated feed-only market of approximately USD 736.4 million in 2025. This derivation is shown transparently, formula-by-formula, in the companion workbook rather than presented as an independently-sourced figure.
Growth in animal feed peptides is being driven by the global shift toward antibiotic-free animal nutrition strategies: bioactive peptides are increasingly positioned as immunomodulatory and antimicrobial alternatives supporting disease resistance without inducing microbial resistance, particularly as regulations tighten on antibiotic growth promoters across Europe, North America and parts of Asia. Collagen peptides and hydrolyzed collagen (24.7% share of the full FMI scope) lead by peptide type, reflecting wide-scale integration into joint, skin and mobility-focused formulations, followed by fish-derived/marine collagen peptides (17.8%) and gelatin hydrolysates (14.5%).
Powder remains the dominant delivery form (58.3% of the full FMI scope), reflecting processing ease, shelf stability and compatibility with feed premixes. By species, poultry leads feed-relevant demand (27.3% of the full scope), followed closely by ruminants (21.6%) and swine (18.9%) — together confirming that intensive livestock production systems, where peptides support feed conversion efficiency, immune function and gut health, anchor the bulk of genuine feed-ingredient demand.
Real UN Comtrade trade-data analysis (HS code 3504, the same classification and dataset used in the companion Food Peptides report, since collagen/protein-hydrolysate peptide trade flows serve both food and feed applications) confirms China as the largest net exporter among reporting countries (~USD 658 million surplus, 2024) and shows strong export growth from Canada (+20.8% CAGR, 2020–2024), South Korea (+19.8%) and Brazil (+18.8%) — well above the category-wide value growth rate, suggesting these origins are gaining share specifically.
The competitive landscape is genuinely fragmented: FMI reports the largest identifiable single-company share (Titan Biotech) at just 4.1%, with "Others" accounting for 95.9% of the market — a materially more fragmented structure than the pharma peptide API or cosmetic peptide markets this report family has previously covered.
Scope of the Global Animal Feed Peptide Market Strategic Research Report
This report provides market sizing (value, derived from a real third-party anchor with a transparently-shown analyst adjustment) across peptide type, animal species and regional segments through 2031, alongside real UN Comtrade trade-data analysis. Full country-level detail is provided for all 5 regions, including Latin America and Middle East & Africa.
Segment by Type
Segment by Animal Species
Who Can Use This Report?
This research report is ideal for people who need a granular view of the global animal feed peptide market rather than aggregate headline narratives. Some of the intended users are:
List of Exhibits
PB Leiner, GELITA AG, Rousselot, Darling Ingredients, Nitta Gelatin, Titan Biotech, Bachem AG, Weishardt International, CPC Scientific, VPEP India, NF Protein
*If Applicable.